Showing 1 - 10 of 96
Persistent link: https://www.econbiz.de/10002010027
Persistent link: https://www.econbiz.de/10001577257
Persistent link: https://www.econbiz.de/10013424211
We analyse the determinants of opposition to biotechnology and pharmaceutical patents granted by the European Patent Office between 1978–96. Opposition can be considered an early form of patent validity challenge suit. In our sample, 8.6% of the patents are attacked in opposition proceedings....
Persistent link: https://www.econbiz.de/10005791233
We present a theoretical and empirical analysis of the fitness of national German (German Commercial Code - Handelsgesetzbuch (HGB)) and international (IAS and US-GAAP) accounting information, as well as European patent data to explain the market values of German manufacturing firms. For the...
Persistent link: https://www.econbiz.de/10010295644
Persistent link: https://www.econbiz.de/10008647592
Persistent link: https://www.econbiz.de/10009267468
Persistent link: https://www.econbiz.de/10009744272
We present a theoretical and empirical analysis of the fitness of national German (German Commercial Code - Handelsgesetzbuch (HGB)) and international (IAS and US-GAAP) accounting information, as well as European patent data to explain the market values of German manufacturing firms. For the...
Persistent link: https://www.econbiz.de/10005083258
We originally investigate the comparative usefulness of patent data as a source of investor information depending on the market cycle (bull/bear market). Based on comprehensive data for firms listed on German exchanges between 1997 and 2002, we demonstrate that patent data contain complementary...
Persistent link: https://www.econbiz.de/10005627338